EQUUS magazine will present "Current and Emerging Musculoskeletal Therapies," a free webinar with David Frisbie, DVM, PhD, on November 21 at 7 p.m. EST.
New and better treatments for horse joint diseases
Dr. David Frisbie will discuss stem cell therapy and other leading treatments for joint disease, as well as the use of platelet-rich plasma in the treatment of injured tendons and ligaments.
In this hour-long presentation, Dr. Frisbie will discuss stem cell therapy and other leading treatments for joint disease, as well as the use of platelet-rich plasma in the treatment of injured tendons and ligaments.
"EQUUS magazine is always looking for opportunities to relay the latest information from the world's top equine researchers on topics critical to horse owners, so we’re delighted to present this free webinar with David Frisbee, hosted by Bayer," said Lindsay Porter, Content Manager of EquiSearch. "Dr. Frisbee can provide the facts based on his years of experience with joint disease and cartilage repair."
Dr. Frisbie received his Bachelor’s Degree in Biochemistry and a Doctor of Veterinary Medicine (DVM) from the University of Wisconsin. He then completed a surgical internship at Cornell University in New York where he began his research in joint disease. Later he obtained a Masters Degree in Joint Pathobiology at Colorado State University while completing a surgical residency.
During his work on his PhD, Dr. Frisbee became Board certified in Large Animal Surgery and is a Diplomate of the American College of Veterinary Surgeons. Post residency, Dr. Frisbee focused on treating joint disease using novel methods such as gene therapy and IRAP. His research interests include: Gene therapy, intra-articular therapeutics and new methods of cartilage repair.
To register for the webinar .